[go: up one dir, main page]

AU2002218081A1 - A method for restoring a foot fat-pad - Google Patents

A method for restoring a foot fat-pad

Info

Publication number
AU2002218081A1
AU2002218081A1 AU2002218081A AU1808102A AU2002218081A1 AU 2002218081 A1 AU2002218081 A1 AU 2002218081A1 AU 2002218081 A AU2002218081 A AU 2002218081A AU 1808102 A AU1808102 A AU 1808102A AU 2002218081 A1 AU2002218081 A1 AU 2002218081A1
Authority
AU
Australia
Prior art keywords
pad
restoring
fat
foot
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218081A
Other languages
English (en)
Inventor
Eric Andre Desrosiers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosyntech Canada Inc
Original Assignee
Biosyntech Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyntech Canada Inc filed Critical Biosyntech Canada Inc
Publication of AU2002218081A1 publication Critical patent/AU2002218081A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Prostheses (AREA)
  • Eye Examination Apparatus (AREA)
  • External Artificial Organs (AREA)
AU2002218081A 2000-11-15 2001-11-14 A method for restoring a foot fat-pad Abandoned AU2002218081A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24822800P 2000-11-15 2000-11-15
US60/248,228 2000-11-15
US24857000P 2000-11-16 2000-11-16
US60/248,570 2000-11-16
US10/055,493 US6989373B2 (en) 2000-11-15 2001-10-29 Method for restoring a fat-pad
US10/055,493 2001-10-29
PCT/CA2001/001586 WO2002039977A2 (fr) 2000-11-15 2001-11-14 Procede de reconstitution d'un coussinet adipeux

Publications (1)

Publication Number Publication Date
AU2002218081A1 true AU2002218081A1 (en) 2002-05-27

Family

ID=27368850

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218081A Abandoned AU2002218081A1 (en) 2000-11-15 2001-11-14 A method for restoring a foot fat-pad

Country Status (9)

Country Link
US (1) US6989373B2 (fr)
EP (1) EP1339393B1 (fr)
JP (1) JP2004517655A (fr)
AT (1) ATE305773T1 (fr)
AU (1) AU2002218081A1 (fr)
CA (1) CA2429009C (fr)
DE (1) DE60113874T2 (fr)
ES (1) ES2250515T3 (fr)
WO (1) WO2002039977A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06014403A (es) * 2004-08-20 2007-05-08 Artes Medical Usa Inc Metodos de administracion de microparticulas combinadas con componentes autologos del cuerpo.
AU2009240509B2 (en) 2008-04-24 2014-08-21 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
ES2619515T3 (es) 2008-04-24 2017-06-26 Medtronic, Inc Partículas de polisacárido rehidratables y esponja
EP2296637B1 (fr) 2008-04-24 2014-04-02 Medtronic, Inc Composition protectrice contenant du chitosane
JP5833919B2 (ja) * 2008-04-24 2015-12-16 メドトロニック，インコーポレイテッド キトサンと酸化多糖とに基づく保護用ゲル
US8230620B2 (en) * 2009-02-26 2012-07-31 Brian Ebel Foot pad for relieving pain
US10239960B2 (en) 2015-06-10 2019-03-26 Rhodia Operations Phosphonated polysaccharides and gels and process for making same
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
FR3044557B1 (fr) * 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
US12133930B2 (en) * 2017-05-24 2024-11-05 Theramicro, Llc System and methods for soft-tissue augmentation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US4911926A (en) * 1988-11-16 1990-03-27 Mediventures Inc. Method and composition for reducing postsurgical adhesions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
CA2212300A1 (fr) * 1997-08-04 1999-02-04 Abdellatif Chenite Gelification in vitro ou in vivo du chitosane et utilisations therapeutiques du chitosane
ES2491866T3 (es) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH

Also Published As

Publication number Publication date
EP1339393A2 (fr) 2003-09-03
WO2002039977A2 (fr) 2002-05-23
US20020094959A1 (en) 2002-07-18
ES2250515T3 (es) 2006-04-16
JP2004517655A (ja) 2004-06-17
CA2429009C (fr) 2012-10-23
EP1339393B1 (fr) 2005-10-05
WO2002039977A3 (fr) 2002-10-31
ATE305773T1 (de) 2005-10-15
DE60113874T2 (de) 2006-07-13
US6989373B2 (en) 2006-01-24
CA2429009A1 (fr) 2002-05-23
DE60113874D1 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
AU2002218081A1 (en) A method for restoring a foot fat-pad
PT865294E (pt) Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
PL338034A1 (en) Nourishing composition for treating bedsores
AU6223190A (en) Novel peptidase and isomerase inhibitors
EA200000994A1 (ru) Применение кабэрголина при лечении синдрома усталых ног
BG103800A (en) Method and composition for the treatment of apnoea
BR0010477A (pt) Processo para compactação de uma trama que contém um material superabsorvente
WO1999005096A3 (fr) Inhibiteurs d'urokinase
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
WO1998048646A3 (fr) Formulation alimentaire contenant de l'acide arachidonique et procede d'utilisation
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
IL153648A0 (en) Novel testosterone ester formulation for human use
EP1634605A3 (fr) traitement de la dyslipidémie chez un patient souffrant de diabète de type 2
WO2001034172A3 (fr) Procedes et compositions pour traiter un syndrome d'insatisfaction
WO2001040177A3 (fr) Esters de vitamine d3 et utilisation de ces ceux-ci
AU7501801A (en) Composition and method for enhancing elasticity of tissue
WO2004052294A3 (fr) Compositions et methodes associees aux formulations de lipide:emodine
WO2003105784A8 (fr) Compositions et procedes pour adoucir, fluidifier et enlever le tissu hyperkeratosique
WO2005063205A3 (fr) Preparations de phosphatidylcholine injectables
EP1223176A3 (fr) Mutations des peptides de l'ERAB/HADH2 humaine, leur structures crystalles rontgen, et les materiaux et des procédés pout l'idntification de leurs inhibiteurs
WO2002064160A8 (fr) Compositions pharmaceutiques inhibant la proliferation vasculaire et leur methode d'utilisation
WO2001051072A3 (fr) Agent antiparasitaire
AUPQ866500A0 (en) Therapeutic compounds and methods
WO2000037067A3 (fr) Traitement de lesions cutanees